Home

JOSEPH LACOB

CIK 1215490 · last filed 2026-05-22

JOSEPH LACOB is a corporate insider who has filed 74 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ALGN, was dated May 22, 2026. Across all open-market trades the lifetime net is −$95.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $175.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$175.32M

Companies

4

Total Filings

74

Lifetime Open-Market Net

-$95.85M

Filer Profile

Reported Address
2820 ORCHARD PARKWAY
SAN JOSE, CA 95131
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALGN Director 1,180,016 $146.84 $173.28M -$95.85M 52 2026-05-22
NPCE Director 142,928 $14.09 $2.01M $0 11 2026-03-24
Orexigen Therapeutics, Inc. (OREX) Delisted Director 117,980 — — $0 5 2011-06-06
EHTH Director 31,786 $0.78 $24.8K $0 4 2007-11-09

Recent Filings

74 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-22 ALGN Mixed +1,745 $0 EDGAR
2026-03-24 NPCE Grant (A) +865 $11.2K EDGAR
2025-12-23 NPCE Grant (A) +678 $11.2K EDGAR
2025-09-22 NPCE Grant (A) +1,131 $11.2K EDGAR
2025-06-24 NPCE Grant (A) +11,696 $101.2K EDGAR
2025-06-09 NPCE Grant (A) — $0 EDGAR
2025-05-22 ALGN Mixed +1,148 $0 EDGAR
2024-06-11 NPCE Grant (A) — $0 EDGAR
2024-05-24 ALGN Grant (A) — $0 EDGAR
2024-05-21 ALGN Exer (M) +1,029 $0 EDGAR
Showing 1–10 of 74
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.